Resmed Inc RMD:NYSE

RT Quote | Last NYSE Arca, VOL From CTA | USD

Last | 04/25/24 EDT

183.42

-0.36 (-0.20%)

Volume

1,078,469

52 week range

132.24 - 243.52

Open0.00
Day High0.00
Day Low0.00
Prev Close183.42
52 Week High243.52
52 Week High Date04/28/23
52 Week Low132.24
52 Week Low Date10/27/23

Key Stats

Market Cap26.979B
Shares Out147.09M
10 Day Average Volume1.17M
Dividend1.92
Dividend Yield1.05%
Beta0.69
YTD % Change6.63

KEY STATS

Open0.00
Day High0.00
Day Low0.00
Prev Close183.42
52 Week High243.52
52 Week High Date04/28/23
52 Week Low132.24
52 Week Low Date10/27/23
Market Cap26.979B
Shares Out147.09M
10 Day Average Volume1.17M
Dividend1.92
Dividend Yield1.05%
Beta0.69
YTD % Change6.63

RATIOS/PROFITABILITY

EPS (TTM)6.50
P/E (TTM)28.22
Fwd P/E (NTM)23.43
EBITDA (TTM)1.397B
ROE (TTM)21.66%
Revenue (TTM)4.504B
Gross Margin (TTM)55.11%
Net Margin (TTM)19.77%
Debt To Equity (MRQ)27.37%

EVENTS

Earnings Date04/25/2024
Ex Div Date02/07/2024
Div Amount0.48
Split Date-
Split Factor-

Latest On Resmed Inc

Stocks making the biggest moves midday: United Airlines, Travelers, Abbott LabsApril 17, 2024CNBC.com
Stocks making the biggest premarket moves: Eli Lilly, Travelers, Alcoa and moreApril 17, 2024CNBC.com
Jim Cramer goes Mad for March with a special Final Four version of Lightning RoundApril 5, 2024CNBC.com
Cramer's Lightning Round: Uber is a buyApril 5, 2024CNBC.com

Content From Our Affiliates

KeyBanc Keeps Their Buy Rating on Resmed (RMD)3 Hours AgoTipRanks
Australian Stocks: ResMed (RMD) Shares Surge on Robust Q3 Results4 Hours AgoTipRanks
Resmed Inc (RMD) Q3 Earnings Cheat SheetApril 23, 2024TipRanks
RBC says small surprise in Lilly’s trial could be viewed as positive for ResMedApril 17, 2024TipRanks
Inspire rises, ResMed slips as Street digests data from Lilly sleep apnea trialsApril 17, 2024TipRanks

Profile

ResMed Inc. is a holding company. The Company, through its subsidiaries, is engaged in the development, manufacturing, distribution and marketing of medical devices and cloud-based software applications that diagnose, treat and manage respiratory disorders, including sleep disordered breathing (SDB), chronic obstructive pulmonary disease, neuromuscular disease and other chronic diseases. The Company’s segments include Sleep and Respiratory Care and Software as a Service. SDB...

Michael Farrell

Chairman of the Board, Chief Executive Officer

Peter Farrell Ph.D.

Chairman Emeritus

Brett Sandercock

Chief Financial Officer

Urvashi Tyagi

Chief Technology Officer

Todd Friedman

Chief Information Security Officer

Michael Rider

General Counsel, Company Secretary, Chief Legal Officer

Address

9001 Spectrum Center Blvd

San Diego, CA

92123-1438

United States

https://www.resmed.com/

Top Peers

SYMBOL	LAST	CHG	%CHG
STE STERIS plc	201.54	-1.26	-0.62%
HOLX Hologic Inc	75.71	-1.00	-1.30%
ZBH Zimmer Biomet Holdings Inc	119.75	-1.42	-1.17%
WAT Waters Corp	308.35	-1.90	-0.61%
IDXX IDEXX Laboratories Inc	489.24	-5.02	-1.02%